Botox and MiraDry are the two procedures most people land on once over-the-counter and prescription topical antiperspirants have failed for axillary hyperhidrosis. Both work. Both are FDA-approved or FDA-cleared for the indication. Both produce dramatic sweat reduction in the trials. They are also fundamentally different products that solve the problem in different ways and that suit different patients.
The decision usually comes down to four practical questions. Do you want a permanent fix or are you okay with periodic maintenance? What does insurance cover for you? How do you feel about a one-time harder procedure versus repeated easier ones? And what’s your time horizon for evaluating whether you got value out of the spend?
Here’s the comparison.
What Each One Actually Does
Botox (botulinum toxin type A) is an injection into the dermis of the underarm. The toxin blocks the chemical signal (acetylcholine release) that the sympathetic nerves use to tell sweat glands to produce sweat. The glands are still there and still functional. The signal just doesn’t reach them. After 4 to 8 months the nerve endings regenerate, the signal returns, and sweat production resumes. The treatment then has to be repeated.
The procedure is 15 to 30 minutes in a clinic. A topical anesthetic is applied. The clinician injects roughly 50 units of Botox per underarm, distributed across 10 to 20 small injections. There’s some immediate stinging. Most patients return to normal activity the same day.
MiraDry uses microwave energy to permanently destroy the sweat glands themselves. The handpiece delivers focused electromagnetic energy through the skin, heating the deeper tissue where the glands sit while a cooling system protects the surface. The heat denatures the gland tissue. The destroyed glands do not regenerate. After healing, the underarm has substantially fewer functional sweat glands, permanently.
The procedure is 60 to 90 minutes per session. Most patients need one session, some need two spaced 3 months apart. The procedure is done under local anesthesia injected before the treatment, so it’s not painful during, but the local injections themselves are uncomfortable and the procedure takes long enough that fatigue and the pressure of the device become noticeable. Recovery includes 1 to 2 weeks of swelling, soreness, and sometimes numbness in the underarm.
Efficacy: Both Work
The published trials are favorable for both.
For Botox, the pivotal axillary hyperhidrosis trials demonstrated approximately 80 to 90 percent reduction in sweat output as measured by gravimetry (weighing absorbent paper before and after a fixed sweat collection period). HDSS scores typically drop by 2 points (3 or 4 down to 1 or 2). About 80 percent of patients have their results last 6 months or longer per cycle.
For MiraDry, the FDA pivotal trial showed approximately 82 percent reduction in sweat output at 12 months. HDSS scores dropped similarly, with 90 percent of patients reporting HDSS 1 or 2 at 12 months versus 100 percent at HDSS 3 or 4 at baseline. The published 5-year follow-up data shows durable results in the majority of patients, though some retreatment is sometimes needed for residual sweating.
Head-to-head comparison trials are limited, but the conclusion across the available literature is that both treatments produce comparable efficacy at the timepoints studied. Neither dominates the other on raw sweat reduction. The practical difference is durability.
Duration: The Biggest Difference
This is where the choice usually gets made.
Botox effects last 4 to 8 months. The mean is about 6 months. Some patients get 8 to 9 months. Some get only 4. There is no test that predicts your individual duration before the first cycle. After the first treatment you’ll know your personal duration profile.
To maintain results long-term, you need to repeat injections at the recurrence point. Most patients land on a 2-to-3-treatments-per-year schedule. Each cycle is a return clinic visit, a re-injection, and a few days of partial loss of effect at the end of the previous cycle while you’re scheduling the next.
MiraDry is one procedure (sometimes two, spaced 3 months apart) and the result is permanent. The 5-year follow-up data shows continued sweat reduction in most patients without retreatment. Some patients elect a second or third session for residual sweating, but the maintenance cadence is once per year at most, often zero.
For a patient who plans to manage axillary hyperhidrosis for decades, the MiraDry math gets favorable quickly. For a patient who’s not sure they’ll continue to want treatment over the long term, or who’s not committed to the harder procedure experience, Botox lets you exit at any time.
Cost: Real Numbers
Botox per cycle costs $800 to $1,500 out of pocket if not covered by insurance. With insurance coverage, the patient cost is often $20 to $200 per cycle as a specialist visit copay plus pharmacy cost (Botox itself is administered from a vial covered as a Part B medication for insurance purposes). For US patients with HMO or PPO coverage who have documented HDSS 3 or 4 and have failed topical antiperspirants, insurance approval is achievable but requires the documentation chain.
If you do 2 cycles per year for 5 years uninsured, that’s 10 cycles at $1,000 each, or roughly $10,000 over 5 years.
MiraDry per session costs $1,500 to $3,000, average around $2,250. Most patients need 1 to 2 sessions, so total cost is typically $2,250 to $4,500 lifetime. Insurance coverage for MiraDry is rare; some insurers will reimburse partially after FDA-approval-based appeals, but most patients pay out of pocket.
The simple math: if you have insurance coverage for Botox, Botox is cheaper for the first 4 to 5 years and roughly equivalent over a 7-to-10-year horizon. If you don’t have coverage for either, MiraDry is dramatically cheaper after the first 2 to 3 years.
The Procedure Experience
Botox is the easier single event. Local discomfort during, normal activity within hours. The repeat factor is what wears on people over years. Each cycle is a half day off work for the appointment, the awareness that you’ll need to schedule another in 6 months, the slight anxiety of late-cycle effects fading before the next injection. Patients who’ve done 4 or 5 cycles describe it as “manageable but I’d rather be done with this.”
MiraDry is the harder single event. The local anesthetic injection is uncomfortable. The 60-to-90-minute procedure is tiring. The week-after recovery includes underarm tenderness, swelling, sometimes a band of numbness or weird sensation that takes weeks to fully resolve. About 5 to 10 percent of patients experience temporary upper-arm numbness from nerve irritation, which usually resolves within months. A small fraction (under 2 percent) have prolonged or permanent numbness.
For MiraDry, you commit to one harder thing once and you’re done. For Botox, you commit to easier things, repeatedly, indefinitely.
Side Effects and Trade-Offs
Botox side effects in the underarm are typically mild and transient: bruising, tenderness, occasional compensatory sweating elsewhere (other parts of the body sweating slightly more, which is uncomfortable for some patients). Systemic side effects from underarm Botox are rare because the dose is small and localized. The main “side effect” of Botox is the time and money involved in maintenance.
MiraDry side effects are more substantial in the immediate window: 1 to 2 weeks of swelling, tenderness, sometimes lump formation in the underarm tissue (which resolves over months), small risk of upper-arm numbness from nerve irritation, occasional small areas of skin hyperpigmentation in darker skin tones. Most resolve within months. The 1 to 2 percent rate of persistent numbness is the most consequential durable side effect to know about.
Compensatory sweating is less common with MiraDry than Botox, which is unintuitive but reflects that the destroyed glands are gone rather than signal-blocked. Some patients still experience compensatory sweating in non-underarm areas after MiraDry; the rate is lower.
Hair reduction is a side effect of MiraDry. The microwave energy that destroys sweat glands also destroys hair follicles in the same area. Most MiraDry patients lose 30 to 70 percent of underarm hair permanently. For some patients this is a benefit. For others it isn’t.
Which One We’d Pick (and When)
For a patient with axillary hyperhidrosis at HDSS 3 or 4 who has failed topicals:
Botox first if any of: insurance covers it; you’re uncertain whether procedure-based treatment is right for you; you’re under 35 with a long potential treatment horizon and want to evaluate before committing; you’re not committed to the recovery downtime of MiraDry; you want the option to stop without consequence.
MiraDry if any of: you’ve already done 2 to 4 cycles of Botox and the recurring procedures are wearing on you; you’re paying out of pocket for both and the cost math favors MiraDry over your expected treatment horizon; you want a definitive solution rather than ongoing management; the underarm hair reduction is a benefit or neutral for you; you’re willing to accept the harder procedure experience for the permanent result.
Neither, yet if you haven’t fully tried Drysol with proper application technique. The escalation order is topical first, then procedural. Many patients who think they need procedural treatment haven’t applied prescription antiperspirants correctly. See Drysol and How to Apply Antiperspirant before scheduling either Botox or MiraDry.
What This Decision Looks Like in Practice
The most common path among patients who end up at procedural treatment looks roughly like this: 6 to 12 months on prescription Drysol (often with hydrocortisone for irritation), conclusion that the topical isn’t enough, first round of Botox under insurance, repeat Botox 1 to 3 more times, then either continued Botox indefinitely or escalation to MiraDry depending on the patient’s tolerance for repeat procedures and the cost-coverage situation.
A smaller cohort goes directly to MiraDry, usually patients who are paying out of pocket regardless and want the one-time-and-done experience.
A small cohort fails both and ends up considering glycopyrrolate (oral medication for hyperhidrosis) or, very rarely, ETS surgery (sympathectomy). ETS in particular has high rates of compensatory sweating and we cover its trade-offs separately at ETS Surgery for Hyperhidrosis.
For most readers landing here, the decision is between Botox and MiraDry, and the right answer is shaped more by your insurance coverage and your time horizon than by efficacy differences in the trials.
Where to Go Next
For deeper context on each:
- Botox for Sweating: Complete Guide
- MiraDry: Honest Review
- The Full Hyperhidrosis Treatment Ladder
- Sweaty Armpits: Causes and What Works
- Iontophoresis vs Botox: For Hands and Feet
Sources
- Onabotulinumtoxin A for the Treatment of Primary Axillary Hyperhidrosis: Pivotal Trial, Journal of the American Academy of Dermatology
- Microwave Thermolysis for Treatment of Primary Axillary Hyperhidrosis: A 12-Month Follow-Up, Dermatologic Surgery
- Long-term Efficacy and Safety of Microwave Therapy for Hyperhidrosis: 5-Year Follow-Up, Lasers in Surgery and Medicine
- Hyperhidrosis: Anatomy, Pathophysiology, and Treatment, StatPearls / NCBI Bookshelf
- Botox for Hyperhidrosis, Cleveland Clinic
- Hyperhidrosis Treatments, International Hyperhidrosis Society
- Hyperhidrosis, American Academy of Dermatology